Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
submitted 1 month, 1 week ago by s2g_ventures

Financing will advance its musculoskeletal product through a clinical proof of activity trial as well as continue the discovery and development of its ongoing pipeline of microbial-based products for human health and well-being.

Feedback or bugs? Email us [email protected]